The impact of pharmacist oriented mode on risk control in a Chinese centralized intravenous admixture service centre
Open Access
- 8 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-10
- https://doi.org/10.1038/s41598-021-85077-w
Abstract
Centralized intravenous admixture service (CIVAS) centres, which are pharmaceutical departments found in Chinese hospitals, provide high-quality intravenous fluids and pharmaceutical services for patients, and errors in their working procedures can lead to adverse consequences. Pharmacists, the primary CIVAS centre personnel, play a role in risk control; however, to date, the effect of pharmacists’ participation in risk management has not been reported. The main aim of this study was to evaluate the pharmacist’s role in risk control and evaluate its impact. A retrospective observational study was designed to assess the principal working process in the CIVAS centre of a provincial healthcare setting. Errors in the main working process were identified, and intervention measures were formulated. The pharmacist intervention effect was evaluated by assessing the identification rate of improper prescriptions; the incidence rate of drug preparation, compounding, packaging and delivery process errors; and expenditures on wasteful drugs. There was a higher identification rate for improper prescriptions after the intervention (P < 0.05), while the incidence of drug preparation (P < 0.05), admixture (P < 0.05), and packaging and delivery errors (P < 0.01) was significantly lower; the total wasteful medication expenditure was also dramatically reduced. The potential creativity of pharmacists in error control can provide dependable intravenous drugs for patients and reduce the running expenditures for CIVAS.Funding Information
- Guangxi Zhuang Region Health Department (Z20170382)
- Scientific Research and Technology Development Program of Guangxi (15277005)
This publication has 18 references indexed in Scilit:
- Chinese centralised intravenous admixture service (CIVAS), an emerging pharmaceutical industry: survey of the recent advances of CIVAS in ChinaEuropean Journal of Hospital Pharmacy, 2017
- Semiautomated aseptic preparation of patient-individual antineoplastic intravenous solutions: first experiences in a German hospital pharmacyEuropean Journal of Hospital Pharmacy, 2015
- Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries—Angolan experienceecancermedicalscience, 2015
- Electronic inventory systems and barcode technology: impact on pharmacy technical accuracy and error liability.Hospital Pharmacy, 2015
- ASHP Guidelines on Compounding Sterile PreparationsAmerican Journal of Health-System Pharmacy, 2014
- The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China’s current healthcare reformHealth Policy and Planning, 2013
- Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costsBMC Cancer, 2011
- Centralized intravenous additive services (CIVAS): The state of the art in 2010Annales Pharmaceutiques Francaises, 2011
- Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility studyBMC Health Services Research, 2008
- The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitalsHealth Policy and Planning, 2005